Pre-exposure prophylaxis of HIV

Indian Journal of Sexually Transmitted Diseases

Volumn 32, Issue 1, 2011, Pages 1-8

  Naswa, Smriti ^a   Marfatia, Y S ^a  

^a Baroda Medical College   (India)

Author keywords

HIV AIDS; issues; pre exposure prophylaxis; trials

Indexed keywords

CREATININE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; MARAVIROC; MICROBICIDE; NEVIRAPINE; RALTEGRAVIR; TENOFOVIR DISOPROXIL; ZIDOVUDINE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; CLINICAL STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; DRUG SAFETY; FANCONI RENOTUBULAR SYNDROME; FATTY LIVER; HEPATITIS B; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; MONOTHERAPY; NAUSEA; NONHUMAN; PATIENT SAFETY; POST EXPOSURE PROPHYLAXIS; PRE EXPOSURE PROPHYLAXIS; PROPHYLAXIS; REVIEW; RISK; RISK REDUCTION; SIDE EFFECT; SINGLE DRUG DOSE; VERTICAL TRANSMISSION;

EID: 79958713010     PISSN: 02537184     EISSN: 19983816     Source Type: Journal    
DOI: 10.4103/0253-7184.81246     Document Type: Review

References (35)

1. Frequently Asked Questions. Available from: http://www.iprexnews. com/studyresults/pdfembargo/englishversion/FAQ%20complete%20Final%20PE.pdf. [Last accessed on 2011 Mar 4].
2. UNAIDS report on the global aids epidemic 2010. Available from: http://www.unaids.org/globalreport/documents/20101123- GlobalReport-full-en.pdf. ISBN 978-92-9173-871-7. [Last accessed on 2011 Mar 6].
3. VOICE Study, a major HIV prevention trial for women, is launched in Zimbabwe. Available from: http://www.mtnstopshiv.org/node/1416 Sept. 16, 2009. [Last accessed on 2011 Mar 3].
4. CDC's Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention. Available from: http://www.cdc.gov/hiv/prep/resources/qa/index.htm. [Last updated2010 July 19]. [Last accessed on 2011 Feb 21].
5. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N Engl J Med 2010;363:27.
6. Post exposure prophylaxis and pre-exposure prophylaxis. Available from: http://www.avert.org/pep-prep-hiv.htm. [Last accessed on 2011 Feb 21].
7. iPrEx: Results of a study of TRUVADA® to prevent HIV infection among MSM. Available from: http://www.hvtn.org/community/iprexbackground.pdf. [Last updated 2010 Nov30]. [Last accessed on 2011 Mar 2].
8. Abbas UL, Anderson RM, Mellors JW. Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings. PLoS ONE 2007;2:e875.
9. Humanized Mouse Infected With HIV Vaginally And Rectally Allows Testing. ScienceDaily [Updated 2009 Apr 21]. Available from: http://www.sciencedaily.com/ releases/2009/04/090420103740.htm. [Last accessed on 2011 Feb 22].
10. Food and Drug Administration. Truvada: Highlights of prescribing information (package insert). Available from:http://www.accessdata.fda.gov/ drugsatfda-docs/label/2008/021752s017lbl.pdf .[Last accessed on 2011 Feb 26].
11. Scaccabarozzi L,Milano M. Before and After: PrEP and PEP. Available from: http://www.thebody.com/content/prev/art42460.html. [Last updated Summer 2007]. [Last accessed on 2011 Mar 6].
12. Highlights of prescribing information-Viread® (tenofovirdisoproxilfuma rate) tablets. Available from: http://www.gilead.com/ pdf/viread-pi.pdf. [Last updated 2010 Oct]. [Last accessed on 2011 Mar 4].
13. Peterson L, Taylor D, Roddy R, Belai G, Phillips P, Nanda K,et al. TenofovirDisoproxilFumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial. PLoSClin Trials 2007;2:e27. Available from: http://www.ncbi. nlm.nih.gov/pmc/articles/PMC1876601/. [Last accessed on 2011 Mar 4].
14. Neff CP, Ndolo T, Tandon A, Habu Y, Akkina R.Oral Pre-Exposure Prophylaxis by Anti-RetroviralsRaltegravir and Maraviroc Protects against HIV-1 Vaginal Transmission in a Humanized Mouse Model. PLoS ONE 2010;5:e15257.
15. PrEP trials timeline. Available from: http://www.globaliprex.com/pdfs/ AVAC-PrEP-timeline-graphic.November-2010.jpg. [Last accessed on 2011 Mar 13].
16. Interim Guidance: Preexposure Prophylaxis for the Prevention of HIV Infection in Men Who Have Sex with Men. MMWR Morb Mortal Wkly Rep 2011;60:65-8. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm?s-cid=mm6003a1-w. Last accessed on 25/2/2011
17. CDC Interim PrEP Guidance Graphic. Available from: http://www.cdc.gov/ nchhstp/newsroom/PrEPMSMGuidanceGraphic.html. [Last accessed on 2011 Feb 25].
18. Pre-Exposure Prophylaxis (PrEP). Available from: http://www.cdc. gov/hiv/prep/. [Last updated on2011 Feb 22]. [Last accessed on 2011 Mar 5].
19. Ongoing Pre-Exposure Prophylaxis (PrEP) Trials. Available from: http://www.avac.org/ht/a/GetDocumentAction/i/3113.[Last updated on 2010 Nov][Last accessed on 2011 Feb 23].
20. Trial shows ARVs can prevent HIV in men who have sex with men, making VOICE Study in women more important than ever. Available from: http://www.mtnstopshiv.org/node/2695.[Last updated on 2010 Nov 23]. [Last accessed on 2011 Mar 3].
21. CDC FACT SHEET- CDC TRIALS: Pre-Exposure Prophylaxis for HIV Prevention. Available from: http://www.cdc.gov/hiv/prep/pdf/PrEP-TrialsFactSheet.pdf. [Last updated on 2011 Feb]. [Last accessed on 2011 Mar 4].
22. Questions and answers. The VOICE HIV Prevention Study. Available from: http://www.niaid.nih.gov/news/qa/pages/voiceqa.aspx. [Last updated on 2009 Sep 15]. [Last accessed on 2011 Mar 3].
23. VOICE (MTN-003). Available from: http://www.mtnstopshiv.org/news/studies/ mtn003. [Last accessed on 2011 Mar 3].
24. VOICE - Vaginal And Oral Interventions To Control The Epidemic Of HIV Looks At Tablets Versus Gel. Available from: http://www.medicalnewstoday.com/ articles/217760.php.[Last updated on 2011 Mar 01]. [Last accessed on 2011 Mar 3].
25. Understanding the Results of iPrEx- A Study of Pre-exposure Prophylaxis (PrEP). Available from: http://www.mtnstopshiv.org/node/2694. [Last updated 2010 Nov23]. [Last accessed on 2011 Mar 3].
26. MTN-001: Adherence and Drug Absorption Study of Oral and Vaginal Gel Preparations of Tenofovir. Available from: http://www.mtnstopshiv. org/news/studies/mtn001/backgrounder. [Last updated on 2011 Feb 28]. [Last accessed on 2011 Mar 13].
27. Singh JA, Mills EJ.The Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong? PLoS Med 2005;2:e234.
28. Garcia-Lerma G, Cong M-E, Mitchell J, et al . Prevention of rectal simian HIV transmission in macaques by intermittent pre-exposure prophylaxis with oral Truvada. Montréal, Canada: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections;2009.
29. Intermittent Oral PrEP May Be as Effective as Daily Oral PrEP for Prevention of Rectal HIV Transmission, Macaque Study Suggests- An Interview With Gerardo Garcia-Lerma. Available from: http://www.thebody.com/content/treat/ art51464.html. [Last updated on 2009 Feb 9]. [Last accessed on 2011 Mar 3].
30. Results of CAPRISA 004 a turning point for HIV prevention, say MTN researchers conducting VOICE. VIENNA, July 19, 2010. Available from: http://www.mtnstopshiv.org/node/2004. [Last accessed on 2011 Mar 13].
31. Understanding the Results of CAPRISA 004. Available from: http://www.mtnstopshiv.org/sites/default/files/attachments/MTN%20 factsheet%20Results-CAP004July%2019-0.pdf. [Last updated on 2010 July20. [Last accessed on 2011 Mar 13].
32. Karim QA, Karim SS, Frohlich JA et al. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science 2010;329:1168-74. Available from:http://www. sciencemag.org/content/329/5996/1168.[Last accessed on 2011 Mar 13].
33. CDC FACT SHEET- Pre-exposure prophylaxis (PrEP) for HIV Prevention- Promoting Safe and Effective Use in the United States. Available from: http://www.cdc.gov/hiv/prep/pdf/PrEPfactsheet.pdf. [Last acessed on 2011 Mar5]. [Last updated on 2011 Feb 25].
34. Interim CDC Guidance on Pre-Exposure Prophylaxis for HIV Prevention in MSM. Available from: http://aids-clinical-care.jwatch.org/cgi/content/full/2011/ 214/1. [Last accessed on 2011 Jan 24].
35. CDC Issues Guidance for Truvada Pre-exposure Prophylaxis. Available from: http://www.hivandhepatitis.com/recent/2011/0201-2011-d.html .2/1/11.[Last accessed on 2011 Feb 25].